Chimeric human / murine monoclonal antibody'are -: (A) Adalimumab, (B) Rituximab, (C) Muromonab, (D) Trastuzumab
Answer is B. Monoclonal mouse IgG1 antibody against human CD20 Rituximab has been approved by the FDA for the treatment of various lymphoid malignancies, including B-cell non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukaemia also used in treatment of ebola . Ref Harrison20th edition pg 1078